Brainstorm Cell Therapeutics Inc. (BCLI)

Operating Expenses

$9.82M

TTM · Period ending: · USD

BCLI logo

BCLI Operating Expenses

Latest reported$9.82M
BCLI TTM Operating Expenses ($40.15K → $9.82M)
High-resolution chart · PNG

BCLI operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Brainstorm Cell Therapeutics Inc. Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
9,819,000
8,825,000
9,905,000
10,898,000
11,899,000
12,308,000
11,693,000
13,242,000
16,229,000
18,696,000
21,373,000
21,550,000
22,356,000
24,498,000
24,822,000
26,119,000
24,555,000
23,085,000
24,539,000
29,818,000
29,026,000
30,305,000
31,684,000
27,858,000
28,924,000
26,381,000
23,001,000
20,773,000
18,454,000
16,684,000
14,063,000
8,388,000
7,548,000
5,536,000
4,999,000
5,887,000
5,133,000
5,041,000
5,083,000
5,830,000
6,763,000
8,143,000
8,536,000
9,805,000
9,664,000
8,595,000
8,501,000
7,071,000
5,717,000
5,908,000
4,878,000
4,277,000
4,373,000
3,721,000
3,519,000
4,287,000
3,855,000
4,437,000
4,086,000
3,412,000
3,307,000
2,506,000
2,587,000
1,951,000
1,909,000
1,819,000
1,750,000
2,332,000
2,436,000
2,674,000
3,268,000
3,186,000
3,946,000
4,047,000
4,251,218
5,744,096
5,176,604
5,146,039
4,432,103
3,261,201
3,400,640
3,301,005
3,230,515
18,917,293
19,462,980
18,738,878
18,218,523
1,631,367
67,770
70,947
40,145
53,869
58,687
57,995
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.